Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Brainstem serotonergic deficiency in sudden infant death syndrome.

Duncan JR, Paterson DS, Hoffman JM, Mokler DJ, Borenstein NS, Belliveau RA, Krous HF, Haas EA, Stanley C, Nattie EE, Trachtenberg FL, Kinney HC.

JAMA. 2010 Feb 3;303(5):430-7. doi: 10.1001/jama.2010.45.

2.

Multiple serotonergic brainstem abnormalities in sudden infant death syndrome.

Paterson DS, Trachtenberg FL, Thompson EG, Belliveau RA, Beggs AH, Darnall R, Chadwick AE, Krous HF, Kinney HC.

JAMA. 2006 Nov 1;296(17):2124-32.

PMID:
17077377
3.

Brainstem deficiency of the 14-3-3 regulator of serotonin synthesis: a proteomics analysis in the sudden infant death syndrome.

Broadbelt KG, Rivera KD, Paterson DS, Duncan JR, Trachtenberg FL, Paulo JA, Stapels MD, Borenstein NS, Belliveau RA, Haas EA, Stanley C, Krous HF, Steen H, Kinney HC.

Mol Cell Proteomics. 2012 Jan;11(1):M111.009530. doi: 10.1074/mcp.M111.009530. Epub 2011 Oct 5.

4.

Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome.

Panigrahy A, Filiano J, Sleeper LA, Mandell F, Valdes-Dapena M, Krous HF, Rava LA, Foley E, White WF, Kinney HC.

J Neuropathol Exp Neurol. 2000 May;59(5):377-84.

5.

Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome.

Kinney HC, Randall LL, Sleeper LA, Willinger M, Belliveau RA, Zec N, Rava LA, Dominici L, Iyasu S, Randall B, Habbe D, Wilson H, Mandell F, McClain M, Welty TK.

J Neuropathol Exp Neurol. 2003 Nov;62(11):1178-91.

6.

Partial Raphe Dysfunction in Neurotransmission Is Sufficient to Increase Mortality after Anoxic Exposures in Mice at a Critical Period in Postnatal Development.

Barrett KT, Dosumu-Johnson RT, Daubenspeck JA, Brust RD, Kreouzis V, Kim JC, Li A, Dymecki SM, Nattie EE.

J Neurosci. 2016 Apr 6;36(14):3943-53. doi: 10.1523/JNEUROSCI.1796-15.2016.

PMID:
27053202
7.

Decreased GABAA receptor binding in the medullary serotonergic system in the sudden infant death syndrome.

Broadbelt KG, Paterson DS, Belliveau RA, Trachtenberg FL, Haas EA, Stanley C, Krous HF, Kinney HC.

J Neuropathol Exp Neurol. 2011 Sep;70(9):799-810. doi: 10.1097/NEN.0b013e31822c09bc.

8.

Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome.

Rognum IJ, Tran H, Haas EA, Hyland K, Paterson DS, Haynes RL, Broadbelt KG, Harty BJ, Mena O, Krous HF, Kinney HC.

J Neuropathol Exp Neurol. 2014 Feb;73(2):115-22. doi: 10.1097/NEN.0000000000000034.

9.

The triple risk hypotheses in sudden infant death syndrome.

Guntheroth WG, Spiers PS.

Pediatrics. 2002 Nov;110(5):e64. Review.

PMID:
12415070
10.

Prenatal nicotine-exposure alters fetal autonomic activity and medullary neurotransmitter receptors: implications for sudden infant death syndrome.

Duncan JR, Garland M, Myers MM, Fifer WP, Yang M, Kinney HC, Stark RI.

J Appl Physiol (1985). 2009 Nov;107(5):1579-90. doi: 10.1152/japplphysiol.91629.2008. Epub 2009 Sep 3.

11.

Serotoninergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with clinical risk factors.

Machaalani R, Say M, Waters KA.

Acta Neuropathol. 2009 Mar;117(3):257-65. doi: 10.1007/s00401-008-0468-x. Epub 2008 Dec 4.

PMID:
19052756
12.

Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.

Jacobsen JP, Siesser WB, Sachs BD, Peterson S, Cools MJ, Setola V, Folgering JH, Flik G, Caron MG.

Mol Psychiatry. 2012 Jul;17(7):694-704. doi: 10.1038/mp.2011.50. Epub 2011 May 3.

13.

Subtle autonomic and respiratory dysfunction in sudden infant death syndrome associated with serotonergic brainstem abnormalities: a case report.

Kinney HC, Myers MM, Belliveau RA, Randall LL, Trachtenberg FL, Fingers ST, Youngman M, Habbe D, Fifer WP.

J Neuropathol Exp Neurol. 2005 Aug;64(8):689-94.

14.

Development of brainstem 5-HT1A receptor-binding sites in serotonin-deficient mice.

Massey CA, Kim G, Corcoran AE, Haynes RL, Paterson DS, Cummings KJ, Dymecki SM, Richerson GB, Nattie EE, Kinney HC, Commons KG.

J Neurochem. 2013 Sep;126(6):749-57. doi: 10.1111/jnc.12311. Epub 2013 Jun 10.

15.

The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.

Duncan JR, Paterson DS, Kinney HC.

Auton Neurosci. 2008 Dec 15;144(1-2):61-75. doi: 10.1016/j.autneu.2008.09.006. Epub 2008 Nov 5. Erratum in: Auton Neurosci. 2009 Jan 28;145(1-2):108.

16.
17.

Medullary serotonergic network deficiency in the sudden infant death syndrome: review of a 15-year study of a single dataset.

Kinney HC, Filiano JJ, White WF.

J Neuropathol Exp Neurol. 2001 Mar;60(3):228-47. Review.

18.

More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides.

Boldrini M, Underwood MD, Mann JJ, Arango V.

Brain Res. 2005 Apr 11;1041(1):19-28.

PMID:
15804496
19.

Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification.

Gutknecht L, Araragi N, Merker S, Waider J, Sommerlandt FM, Mlinar B, Baccini G, Mayer U, Proft F, Hamon M, Schmitt AG, Corradetti R, Lanfumey L, Lesch KP.

PLoS One. 2012;7(8):e43157. doi: 10.1371/journal.pone.0043157. Epub 2012 Aug 17.

20.

Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome.

Nonnis Marzano F, Maldini M, Filonzi L, Lavezzi AM, Parmigiani S, Magnani C, Bevilacqua G, Matturri L.

Genomics. 2008 Jun;91(6):485-91. doi: 10.1016/j.ygeno.2008.01.010. Epub 2008 Apr 2.

Items per page

Supplemental Content

Write to the Help Desk